Range Low Price High Price Comment
30 days $3.26 $4.01 Monday, 29th Apr 2024 ALIM stock ended at $3.67. This is 5.16% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 7.38% from a day low at $3.45 to a day high of $3.70.
90 days $3.07 $4.26
52 weeks $1.56 $4.38

Historical Alimera Sciences prices

Date Open High Low Close Volume
Feb 01, 2016 $2.29 $2.29 $2.29 $2.29 47 000
Jan 29, 2016 $2.31 $2.31 $2.31 $2.31 112 100
Jan 28, 2016 $2.11 $2.11 $2.11 $2.11 71 400
Jan 27, 2016 $2.16 $2.16 $2.16 $2.16 80 000
Jan 26, 2016 $2.26 $2.26 $2.26 $2.26 135 200
Jan 25, 2016 $2.20 $2.20 $2.20 $2.20 95 300
Jan 22, 2016 $2.28 $2.28 $2.28 $2.28 141 000
Jan 21, 2016 $2.19 $2.19 $2.19 $2.19 117 700
Jan 20, 2016 $2.11 $2.11 $2.11 $2.11 178 800
Jan 19, 2016 $2.04 $2.04 $2.04 $2.04 248 900
Jan 15, 2016 $2.07 $2.07 $2.07 $2.07 151 300
Jan 14, 2016 $2.10 $2.10 $2.10 $2.10 176 100
Jan 13, 2016 $1.97 $1.97 $1.97 $1.97 263 200
Jan 12, 2016 $2.14 $2.14 $2.14 $2.14 175 300
Jan 11, 2016 $2.19 $2.19 $2.19 $2.19 430 500
Jan 08, 2016 $2.39 $2.39 $2.39 $2.39 72 300
Jan 07, 2016 $2.32 $2.32 $2.32 $2.32 191 400
Jan 06, 2016 $2.52 $2.52 $2.52 $2.52 161 100
Jan 05, 2016 $2.65 $2.65 $2.65 $2.65 275 300
Click to get the best stock tips daily for free!

About Alimera Sciences

Alimera Sciences Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affectin... ALIM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT